Prezcobix FDA Approval History
FDA Approved: Yes (First approved January 29, 2015)
Brand name: Prezcobix
Generic name: cobicistat and darunavir
Dosage form: Tablets
Company: Janssen Pharmaceuticals, Inc.
Treatment for: HIV Infection
Prezcobix (darunavir and cobicistat) is a once-daily fixed-dose combination containing a protease inhibitor and a pharmacokinetic enhancer for the treatment of HIV-1 infection.
Development Timeline for Prezcobix
|Jan 29, 2015||FDA Approves Prezcobix (darunavir and cobicistat) for HIV-1 Infection in Adults|
|Apr 1, 2014||Janssen Submits NDA for a Fixed-Dose Combination of Darunavir with Cobicistat|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.